Validation of the Pain Relief Measure

NCT05294432 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2025-03-25

No results posted yet for this study

Summary

The purpose of this study is to provide evidence for the empirical and clinical utility of a novel pain relief measure, the IPR, dimensions of which will be validated against the present gold standards for pain measurement.

Conditions

Sponsors & Collaborators

  • Wilderman Medical Clinic

    lead OTHER

Principal Investigators

  • Igor Wilderman, MD · Wilderman Medical Clinic

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-28
Primary Completion
2024-10-21
Completion
2024-10-21

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05294432 on ClinicalTrials.gov